Isotopologues of 5-azacytidine
US10646503B2 · kind B2 · utility
2Cited by
25References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 25, 2019 |
| Grant date | May 12, 2020 |
| Priority date | — |
| Expiry date | Sep 25, 2039 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure provides pharmaceutical compositions comprising cytidine analogs for oral administration, wherein the compositions release the cytidine analog substantially in the stomach. Also provided are methods of treating diseases and disorders using the oral formulations provided herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.